Pacelli Steven Robert 4
4 · DEXCOM INC · Filed Sep 22, 2023
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Transactions
- Sale
Common Stock
2023-09-22$88.40/sh−411$36,332→ 125,597 total
Footnotes (2)
- [F1]On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- [F2]Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.